Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rottenberg

Showing results (681-690 of 684) with videos related to

Pageof 69
Sort By:
You have reached the last page of results.This site can display upto 684 results.
Cancer Cell|February 19, 2019
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate CancerLaura Cato, Jonas de Tribolet-Hardy, Irene Lee, et al.
The American Psychologist|August 11, 2020
Mental health and clinical psychological science in the time of COVID-19: Challenges, opportunities, and a call to actionJune Gruber, Mitchell J Prinstein, Lee Anna Clark, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
The Lancet. Oncology|June 29, 2026
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trialRianne L Seefat, Sonja B Vliek, Vincent M T de Jong, et al.
Pageof 69

Showing results (681-690 of 684) with videos related to

Sort By:
Pageof 69
You have reached the last page of results.This site can display upto 684 results.
Cancer Cell|February 19, 2019
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate CancerLaura Cato, Jonas de Tribolet-Hardy, Irene Lee, et al.
The American Psychologist|August 11, 2020
Mental health and clinical psychological science in the time of COVID-19: Challenges, opportunities, and a call to actionJune Gruber, Mitchell J Prinstein, Lee Anna Clark, et al.
Nature|August 10, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, et al.
The Lancet. Oncology|June 29, 2026
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trialRianne L Seefat, Sonja B Vliek, Vincent M T de Jong, et al.
Pageof 69